Page 2 - Curevac En News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Curevac en. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Curevac En Today - Breaking & Trending Today

Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made. ....

How Well Is Curevac , Should We Worry About Curevac , Free Cash Flow ,

CureVac (NASDAQ:CVAC) Short Interest Down 11.6% in December

CureVac (NASDAQ:CVAC – Get Free Report) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 3,750,000 shares, a drop of 11.6% from the November 30th total of 4,240,000 shares. Currently, 4.1% of the shares of the company are sold short. Based on an […] ....

China Universal Asset Management Co , Cubist Systematic Strategies , Optiver Holding , Us Bancorp , Get Free Report , Vac Stock Down , Universal Asset Management , Curevac Daily , Nasdaq Cvac ,

These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts

One thing we could say about the analysts on CureVac N.V. ( NASDAQ:CVAC ) - they aren't optimistic, having just made a. ....

Revenue Estimates , Arnings Per Share ,

CureVac (NASDAQ:CVAC) Hits New 12-Month Low at $3.41

CureVac (NASDAQ:CVAC – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $3.41 and last traded at $3.93, with a volume of 4123767 shares changing hands. The stock had previously closed at $5.82. CureVac Stock Down 3.4 % The business’s 50 day […] ....

Blackrock Inc , Citigroup Inc , Jpmorgan Chase Co , York Mellon Corp , Healthcare Of Ontario Pension Plan Trust Fund , Get Free Report , Vac Stock Down , New York Mellon Corp , Ontario Pension Plan Trust Fund , Curevac Daily , Nasdaq Cvac ,

German court quashes CureVac patent after challenge by BioNTech

MUNICH (Reuters) -A German court on Tuesday invalidated a patent that was the basis of a patent violation lawsuit brought by CureVac against its domestic rival BioNTech, in a blow to CureVac's claims for a share in billions of euros in COVID-19 vaccine revenues. "The patent is being declared invalid for the territory of the Federal Republic of Germany," Walter Schramm, presiding judge in Germany's patent court, said in his ruling after a hearing. CureVac's Frankfurt-listed shares plunged 40% after the verdict. ....

Federal Republic Of Germany , Walter Schramm , Hugh Lawson , Joern Poltz , Ludwig Burger , Federal Republic , Rachel More , Patent Infringement , Patent Violation , German Court ,